Long-Term Outcomes of Osteochondral Allograft with Osteogenic Protein-1 Augmentation: A Twelve-Year Follow-Up
Background. Osteochondral lesions (OCLs) can significantly impact functional status and activities of daily living. Weightbearing joints are disproportionately affected due to considerable biomechanical forces in these areas. Various biologic reconstructive procedures such as microfracture, osteocho...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-01-01
|
| Series: | Case Reports in Orthopedics |
| Online Access: | http://dx.doi.org/10.1155/2023/3842443 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832547840796131328 |
|---|---|
| author | Eric Assid Andrew Renshaw Mawadah Samad Richard Tupler Deryk Jones |
| author_facet | Eric Assid Andrew Renshaw Mawadah Samad Richard Tupler Deryk Jones |
| author_sort | Eric Assid |
| collection | DOAJ |
| description | Background. Osteochondral lesions (OCLs) can significantly impact functional status and activities of daily living. Weightbearing joints are disproportionately affected due to considerable biomechanical forces in these areas. Various biologic reconstructive procedures such as microfracture, osteochondral autograft transfer (OATS) or allograft transplantation (OCA), and matrix-induced autologous chondrocyte implantation (MACI) are utilized by surgeons to treat OCLs. The integration of osteochondral allografts can restore knee function and maintain the integrity of adjacent joint surfaces. Bone incorporation has been linked to successful outcomes following OCA. Pulse lavage and carbon dioxide have been used to remove marrow elements from the superficial, middle, and deep layers of the allograft; this has been combined with the use of various biologics such as bone marrow aspirate or whole blood to augment donor bone incorporation into the host bone. We present an innovative augmentation approach in OCA transplantation demonstrating excellent incorporation of an osteogenic protein-1 (OP-1) implant (Stryker, Kalamazoo, MI) to treat a large fresh osteoarticular allograft. Case Presentation. We present a 51-year-old male who received OCA augmented with an OP-1 implant (Stryker, Kalamazoo, MI) in 2011. Due to subsequent ACL reconstruction for two years and medial meniscal repair four years following OCA transplantation, we were able to arthroscopically evaluate graft status at short- and intermediate-term follow-ups. Positive findings were further verified with radiographic imaging and patient-reported outcome measures (PROMs). Conclusion. OP-1 implants aided in the bone incorporation of a large osteochondral allograft, restoring a high functional level in a demanding sport. |
| format | Article |
| id | doaj-art-52299546c5444ffa820c58b170898c3e |
| institution | Kabale University |
| issn | 2090-6757 |
| language | English |
| publishDate | 2023-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Orthopedics |
| spelling | doaj-art-52299546c5444ffa820c58b170898c3e2025-02-03T06:43:12ZengWileyCase Reports in Orthopedics2090-67572023-01-01202310.1155/2023/3842443Long-Term Outcomes of Osteochondral Allograft with Osteogenic Protein-1 Augmentation: A Twelve-Year Follow-UpEric Assid0Andrew Renshaw1Mawadah Samad2Richard Tupler3Deryk Jones4Ochsner Health SystemOchsner Health SystemThe University of QueenslandOchsner Health SystemOchsner Health SystemBackground. Osteochondral lesions (OCLs) can significantly impact functional status and activities of daily living. Weightbearing joints are disproportionately affected due to considerable biomechanical forces in these areas. Various biologic reconstructive procedures such as microfracture, osteochondral autograft transfer (OATS) or allograft transplantation (OCA), and matrix-induced autologous chondrocyte implantation (MACI) are utilized by surgeons to treat OCLs. The integration of osteochondral allografts can restore knee function and maintain the integrity of adjacent joint surfaces. Bone incorporation has been linked to successful outcomes following OCA. Pulse lavage and carbon dioxide have been used to remove marrow elements from the superficial, middle, and deep layers of the allograft; this has been combined with the use of various biologics such as bone marrow aspirate or whole blood to augment donor bone incorporation into the host bone. We present an innovative augmentation approach in OCA transplantation demonstrating excellent incorporation of an osteogenic protein-1 (OP-1) implant (Stryker, Kalamazoo, MI) to treat a large fresh osteoarticular allograft. Case Presentation. We present a 51-year-old male who received OCA augmented with an OP-1 implant (Stryker, Kalamazoo, MI) in 2011. Due to subsequent ACL reconstruction for two years and medial meniscal repair four years following OCA transplantation, we were able to arthroscopically evaluate graft status at short- and intermediate-term follow-ups. Positive findings were further verified with radiographic imaging and patient-reported outcome measures (PROMs). Conclusion. OP-1 implants aided in the bone incorporation of a large osteochondral allograft, restoring a high functional level in a demanding sport.http://dx.doi.org/10.1155/2023/3842443 |
| spellingShingle | Eric Assid Andrew Renshaw Mawadah Samad Richard Tupler Deryk Jones Long-Term Outcomes of Osteochondral Allograft with Osteogenic Protein-1 Augmentation: A Twelve-Year Follow-Up Case Reports in Orthopedics |
| title | Long-Term Outcomes of Osteochondral Allograft with Osteogenic Protein-1 Augmentation: A Twelve-Year Follow-Up |
| title_full | Long-Term Outcomes of Osteochondral Allograft with Osteogenic Protein-1 Augmentation: A Twelve-Year Follow-Up |
| title_fullStr | Long-Term Outcomes of Osteochondral Allograft with Osteogenic Protein-1 Augmentation: A Twelve-Year Follow-Up |
| title_full_unstemmed | Long-Term Outcomes of Osteochondral Allograft with Osteogenic Protein-1 Augmentation: A Twelve-Year Follow-Up |
| title_short | Long-Term Outcomes of Osteochondral Allograft with Osteogenic Protein-1 Augmentation: A Twelve-Year Follow-Up |
| title_sort | long term outcomes of osteochondral allograft with osteogenic protein 1 augmentation a twelve year follow up |
| url | http://dx.doi.org/10.1155/2023/3842443 |
| work_keys_str_mv | AT ericassid longtermoutcomesofosteochondralallograftwithosteogenicprotein1augmentationatwelveyearfollowup AT andrewrenshaw longtermoutcomesofosteochondralallograftwithosteogenicprotein1augmentationatwelveyearfollowup AT mawadahsamad longtermoutcomesofosteochondralallograftwithosteogenicprotein1augmentationatwelveyearfollowup AT richardtupler longtermoutcomesofosteochondralallograftwithosteogenicprotein1augmentationatwelveyearfollowup AT derykjones longtermoutcomesofosteochondralallograftwithosteogenicprotein1augmentationatwelveyearfollowup |